-+ 0.00%
-+ 0.00%
-+ 0.00%

*CorMedix Suspends 2027 DefenCath Revenue Guidance Due to Recently Announced Changes to CMS Reimbursement Framework >CRMD

Dow Jones·11/12/2026 12:37:41